MUC16 and ovarian carcinoma: Furthermore, the evaluation of DNA-methylation in cell-free DNA seems to be superior to cancer antigen 125 (CA125) as a tool of evaluation of ovarian cancer risk and in discerning healthy women from ovarian cancer patients [108].